- Home
- LSBK vs SERA Comparison
LSBK vs SERA Comparison
Compare LSBK & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- SERA
- Stock Information
- Founded
- LSBK 1891
- SERA 2008
- Country
- LSBK United States
- SERA United States
- Employees
- LSBK N/A
- SERA N/A
- Industry
- LSBK Savings Institutions
- SERA Precision Instruments
- Sector
- LSBK Finance
- SERA Health Care
- Exchange
- LSBK Nasdaq
- SERA Nasdaq
- Market Cap
- LSBK 90.0M
- SERA 90.6M
- IPO Year
- LSBK 2006
- SERA 2021
- Fundamental
- Price
- LSBK $13.03
- SERA $3.08
- Analyst Decision
- LSBK
- SERA
- Analyst Count
- LSBK 0
- SERA 0
- Target Price
- LSBK N/A
- SERA N/A
- AVG Volume (30 Days)
- LSBK 28.8K
- SERA 107.3K
- Earning Date
- LSBK 10-22-2025
- SERA 11-05-2025
- Dividend Yield
- LSBK 2.76%
- SERA N/A
- EPS Growth
- LSBK 39.59
- SERA N/A
- EPS
- LSBK 1.05
- SERA N/A
- Revenue
- LSBK $26,488,000.00
- SERA $108,000.00
- Revenue This Year
- LSBK N/A
- SERA $257.66
- Revenue Next Year
- LSBK N/A
- SERA $435.22
- P/E Ratio
- LSBK $12.48
- SERA N/A
- Revenue Growth
- LSBK 1.75
- SERA 0.94
- 52 Week Low
- LSBK $11.50
- SERA $1.37
- 52 Week High
- LSBK $13.48
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- LSBK 55.76
- SERA 55.90
- Support Level
- LSBK $12.96
- SERA $3.01
- Resistance Level
- LSBK $13.26
- SERA $3.24
- Average True Range (ATR)
- LSBK 0.19
- SERA 0.27
- MACD
- LSBK -0.06
- SERA -0.01
- Stochastic Oscillator
- LSBK 28.57
- SERA 39.37
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.